Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating expenses:        
Research and development $ 1,817,959 $ 1,449,508 $ 3,306,798 $ 2,311,928
General and administrative 6,160,812 4,314,552 10,539,709 6,086,348
Depreciation and amortization 9,979 2,926 17,914 5,829
Total operating expenses 7,988,750 5,766,986 13,864,421 8,404,105
Loss from operations (7,988,750) (5,766,986) (13,864,421) (8,404,105)
Other income (expense):        
Interest income 39,146 263 45,269 348
Loss before income taxes (7,949,604) (5,766,723) (13,819,152) (8,403,757)
Income taxes (benefit) 0 0    
Net loss (7,949,604) (5,766,723) (13,819,152) (8,403,757)
Preferred stock dividend (4,868) (280,867) (15,409) (585,913)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (7,954,472) $ (6,047,590) $ (13,834,561) $ (8,989,670)
Net loss per common share, basic and diluted (in Dollars per share) $ (0.38) $ (0.44) $ (0.72) $ (0.70)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 20,671,193 13,807,284 19,267,514 12,897,585